BerGenBio ASA
BRRGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,403 | $2,424 | $1,337 | $1,424 |
| - Cash | $140,155 | $155,969 | $150,071 | $435,890 |
| + Debt | $818 | $418 | $275 | $1,623 |
| Enterprise Value | -$135,934 | -$153,127 | -$148,459 | -$432,843 |
| Revenue | $848 | $354 | $389 | $774 |
| % Growth | 139.5% | -9% | -49.7% | – |
| Gross Profit | $848 | $354 | $389 | $774 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$134,126 | -$189,600 | -$300,918 | -$307,999 |
| % Margin | -15,816.7% | -53,559.3% | -77,356.8% | -39,793.2% |
| Net Income | -$139,282 | -$190,401 | -$298,609 | -$309,417 |
| % Margin | -16,424.8% | -53,785.6% | -76,763.2% | -39,976.4% |
| EPS Diluted | -11.65 | -19.95 | -38.65 | -40.36 |
| % Growth | 41.6% | 48.4% | 4.2% | – |
| Operating Cash Flow | -$153,242 | -$225,101 | -$288,231 | -$303,340 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$153,242 | -$225,101 | -$288,231 | -$303,340 |